Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients-Reference-Cited by-同舟云学术

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Published:2020-10-08 Issue:52 Volume:5 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Iyer Anita S.¹²^ORCID,Jones Forrest K.³,Nodoushani Ariana¹^ORCID,Kelly Meagan¹,Becker Margaret¹^ORCID,Slater Damien¹^ORCID,Mills Rachel¹^ORCID,Teng Erica¹^ORCID,Kamruzzaman Mohammad¹^ORCID,Garcia-Beltran Wilfredo F.⁴,Astudillo Michael⁴,Yang Diane⁴^ORCID,Miller Tyler E.⁴^ORCID,Oliver Elizabeth¹^ORCID,Fischinger Stephanie⁵^ORCID,Atyeo Caroline⁵^ORCID,Iafrate A. John⁴^ORCID,Calderwood Stephen B.¹²⁶^ORCID,Lauer Stephen A.³^ORCID,Yu Jingyou⁷^ORCID,Li Zhenfeng⁷,Feldman Jared⁵^ORCID,Hauser Blake M.⁵^ORCID,Caradonna Timothy M.⁵^ORCID,Branda John A.⁴,Turbett Sarah E.¹²⁴^ORCID,LaRocque Regina C.¹²^ORCID,Mellon Guillaume¹^ORCID,Barouch Dan H.⁵⁷^ORCID,Schmidt Aaron G.⁵⁶^ORCID,Azman Andrew S.³^ORCID,Alter Galit⁵^ORCID,Ryan Edward T¹²⁸,Harris Jason B.¹⁹^ORCID,Charles Richelle C.¹²

Affiliation:

1. Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

2. Department of Medicine, Harvard Medical School, Boston, MA, USA.

3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

4. Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.

5. Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.

6. Department of Microbiology, Harvard Medical School, Boston, MA, USA.

7. Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

8. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

9. Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Abstract

IgM and IgA responses to SARS-CoV-2 RBD in severe COVID patients decay rapidly, while IgG responses persist for over 3 months.

Funder

National Institutes of Health

Centers for Disease Control and Prevention

MassCPR

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference27 articles.

1. Defining the Epidemiology of Covid-19 — Studies Needed

2. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. Accessed 28th September 2020.

3. Dissecting antibody-mediated protection against SARS-CoV-2

4. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity

5. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Cited by 553 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Omicron SARS-CoV-2 serostatus in Sierra Leone: A cross-sectional study in a maternity hospital setting in Freetown, November/December 2022;Journal of Infection and Public Health;2024-09

2. COVID-19: from immune response to clinical intervention;Precision Clinical Medicine;2024-07-18

3. Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells;Frontiers in Immunology;2024-07-18

4. Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors;Transfusion and Apheresis Science;2024-06

5. Lessons to be learned from test evaluations during the COVID-19 pandemic: RSS Working Group’s Report on Diagnostic Tests;Journal of the Royal Statistical Society Series A: Statistics in Society;2024-05-30